AllianceBernstein’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.51M | Buy |
299,077
+235,257
| +369% | +$4.45M | ﹤0.01% | 1394 |
|
|
2026
Q1 | $1.37M | Sell |
63,820
-44,605
| -41% | -$863K | ﹤0.01% | 2197 |
|
|
2025
Q4 | $2.33M | Buy |
108,425
+20,082
| +23% | +$423K | ﹤0.01% | 1910 |
|
|
2025
Q3 | $1.7M | Sell |
88,343
-60,066
| -40% | -$1.07M | ﹤0.01% | 2094 |
|
|
2025
Q2 | $2.54M | Buy |
148,409
+15,285
| +11% | +$652K | ﹤0.01% | 1810 |
|
|
2025
Q1 | $8.5M | Sell |
133,124
-46,784
| -26% | -$4.92M | ﹤0.01% | 1240 |
|
|
2024
Q4 | $21.9M | Sell |
179,908
-39,102
| -18% | -$4.79M | 0.01% | 870 |
|
|
2024
Q3 | $27.4M | Buy |
219,010
+4,639
| +2% | +$641K | 0.01% | 796 |
|
|
2024
Q2 | $33.9M | Sell |
214,371
-103,866
| -33% | -$13.3M | 0.01% | 724 |
|
|
2024
Q1 | $41.2M | Buy |
318,237
+62,326
| +24% | +$7.63M | 0.01% | 658 |
|
|
2023
Q4 | $24.7M | Sell |
255,911
-217,741
| -46% | -$20.9M | 0.01% | 800 |
|
|
2023
Q3 | $57.4M | Sell |
473,652
-27,649
| -6% | -$3.13M | 0.02% | 521 |
|
|
2023
Q2 | $57.4M | Buy |
501,301
+11,069
| +2% | +$1.43M | 0.02% | 540 |
|
|
2023
Q1 | $67.6M | Buy |
490,232
+381,524
| +351% | +$49.5M | 0.03% | 486 |
|
|
2022
Q4 | $14.1M | Sell |
108,708
-30,901
| -22% | -$3.58M | 0.01% | 942 |
|
|
2022
Q3 | $15.4M | Sell |
139,609
-80,467
| -37% | -$8.11M | 0.01% | 918 |
|
|
2022
Q2 | $16.5M | Sell |
220,076
-34,988
| -14% | -$2.57M | 0.01% | 930 |
|
|
2022
Q1 | $19.9M | Buy |
255,064
+149,631
| +142% | +$11.5M | 0.01% | 928 |
|
|
2021
Q4 | $9.49M | Sell |
105,433
-34,430
| -25% | -$2.94M | ﹤0.01% | 1276 |
|
|
2021
Q3 | $12.9M | Buy |
139,863
+100,935
| +259% | +$7.77M | 0.01% | 1113 |
|
|
2021
Q2 | $3.03M | Sell |
38,928
-9,537
| -20% | -$723K | ﹤0.01% | 1931 |
|
|
2021
Q1 | $3.61M | Sell |
48,465
-450,906
| -90% | -$41.6M | ﹤0.01% | 1757 |
|
|
2020
Q4 | $85.1M | Buy |
499,371
+37,212
| +8% | +$5.51M | 0.04% | 426 |
|
|
2020
Q3 | $64.9M | Sell |
462,159
-52,100
| -10% | -$7.92M | 0.03% | 470 |
|
|
2020
Q2 | $82.5M | Buy |
514,259
+47,031
| +10% | +$6.4M | 0.05% | 373 |
|
|
2020
Q1 | $45.7M | Buy |
467,228
+11,592
| +3% | +$1.33M | 0.03% | 471 |
|
|
2019
Q4 | $58.8M | Sell |
455,636
-81,938
| -15% | -$8.27M | 0.03% | 507 |
|
|
2019
Q3 | $40.5M | Buy |
537,574
+42,946
| +9% | +$5.07M | 0.03% | 586 |
|
|
2019
Q2 | $75.2M | Sell |
494,628
-79,807
| -14% | -$9.7M | 0.05% | 405 |
|
|
2019
Q1 | $68.5M | Sell |
574,435
-20,606
| -3% | -$2.65M | 0.04% | 425 |
|
|
2018
Q4 | $64.9M | Buy |
595,041
+324,130
| +120% | +$40.5M | 0.05% | 379 |
|
|
2018
Q3 | $43.8M | Sell |
270,911
-126,744
| -32% | -$17.3M | 0.03% | 572 |
|
|
2018
Q2 | $52.6M | Buy |
397,655
+206,455
| +108% | +$19.5M | 0.04% | 490 |
|
|
2018
Q1 | $14.2M | Buy |
191,200
+73,860
| +63% | +$4.93M | 0.01% | 861 |
|
|
2017
Q4 | $6.53M | Sell |
117,340
-52,800
| -31% | -$2.8M | ﹤0.01% | 1094 |
|
|
2017
Q3 | $7.72M | Buy |
170,140
+51,830
| +44% | +$2.07M | 0.01% | 1028 |
|
|
2017
Q2 | $3.99M | Buy |
118,310
+45,860
| +63% | +$1.49M | ﹤0.01% | 1339 |
|
|
2017
Q1 | $2.15M | Hold |
72,450
| – | – | ﹤0.01% | 1765 |
|
|
2016
Q4 | $1.99M | Buy |
72,450
+9,700
| +15% | +$390K | ﹤0.01% | 1850 |
|
|
2016
Q3 | $3.85M | Sell |
62,750
-29,800
| -32% | -$901K | ﹤0.01% | 1280 |
|
|
2016
Q2 | $1.76M | Buy |
92,550
+23,500
| +34% | +$435K | ﹤0.01% | 1827 |
|
|
2016
Q1 | $1.35M | Hold |
69,050
| – | – | ﹤0.01% | 1906 |
|
|
2015
Q4 | $2.66M | Sell |
69,050
-600
| -0.9% | -$19.5K | ﹤0.01% | 1411 |
|
|
2015
Q3 | $2.24M | Buy |
69,650
+750
| +1% | +$25.4K | ﹤0.01% | 1559 |
|
|
2015
Q2 | $2.1M | Buy |
68,900
+8,700
| +14% | +$178K | ﹤0.01% | 1758 |
|
|
2015
Q1 | $799K | Sell |
60,200
-7,100
| -11% | -$94.6K | ﹤0.01% | 2300 |
|
|
2014
Q4 | $974K | Hold |
67,300
| – | – | ﹤0.01% | 2214 |
|
|
2014
Q3 | $1.42M | Hold |
67,300
| – | – | ﹤0.01% | 1966 |
|
|
2014
Q2 | $2M | Hold |
67,300
| – | – | ﹤0.01% | 1767 |
|
|
2014
Q1 | $1.62M | Hold |
67,300
| – | – | ﹤0.01% | 1864 |
|
|
2013
Q4 | $1.37M | Hold |
67,300
| – | – | ﹤0.01% | 1972 |
|
|
2013
Q3 | $3.18M | Sell |
67,300
-212,502
| -76% | -$8.18M | ﹤0.01% | 1359 |
|
|
2013
Q2 | $10.6M | Buy |
+279,802
| New | +$10M | 0.01% | 785 |
|
Other funds holding SRPT
EAM
AllianceBernstein's SRPT Position: Q2 2026 in Review
AllianceBernstein increased its Sarepta Therapeutics (SRPT) stake by 369% in Q2 2026, buying an estimated $4.45M and bringing the position to 299,077 shares worth $6.51M. The position accounts for ﹤0.01% of the portfolio, ranked #1394.
AllianceBernstein first reported a position in SRPT in Q2 2013 and has held it in 53 quarters since. The position peaked at $85.1M in Q4 2020. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.
- AllianceBernstein held 299,077 shares of Sarepta Therapeutics worth $6.51M as of Q2 2026.
- AllianceBernstein bought 235,257 Sarepta Therapeutics shares in Q2 2026, an estimated $4.45M.
- Sarepta Therapeutics made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #1394 holding.
- AllianceBernstein first reported a position in Sarepta Therapeutics in Q2 2013 and has held it in 53 quarters since.
- AllianceBernstein's Sarepta Therapeutics position peaked at $85.1M in Q4 2020.
- 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.
Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.